Search
×
FR

Placeholder headline

This is just a placeholder headline

API MPMS CH 10.8, 3rd Edition: Standard Test Method for Sediment in Crude Oil by Membrane Filtration

$

114

BUY NOW

Placeholder headline

This is just a placeholder headline

ISO/TR 42505:2026 Sharing economy — Shared manufacturing — Concepts and models

$

192

BUY NOW

Placeholder headline

This is just a placeholder headline

ISO 4306-1:2026 Cranes — Vocabulary — Part 1: General

$

436

BUY NOW

ISO 5499:2024

ISO 5499:2024 Health informatics – Clinical particulars – Core principles for the harmonization of therapeutic indications terms and identifiers

CDN $263.00

Description

The objective of this document is to establish common principles for the creation, assessment, selection and maintenance of maps between terminological resources used to describe and code IDMP therapeutic indications for investigational and medicinal products, medical devices, combination products, biologics and companion diagnostics. Core maintenance principles, such as reliability, reproducibility and quality assurance of the maps for future indication terminology use, are also discussed. The intended audience for this document includes:

a)       Global regulators, pharmaceutical/biopharmaceutical companies, Clinical Research Organizations (CROs) and universities/scientific institutes involved in the development, authorization and marketing of medicinal products

b)       Implementers of IDMP seeking more information about coding of Therapeutic Indications

c)        Healthcare providers

d)       Standards Organizations

e)       Implementers and software vendors developing and implementing terminology map sets

f)         Patients

Edition

1

Published Date

2024-01-31

Status

PUBLISHED

Pages

23

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

The objective of this document is to establish common principles for the creation, assessment, selection and maintenance of maps between terminological resources used to describe and code IDMP therapeutic indications for investigational and medicinal products, medical devices, combination products, biologics and companion diagnostics. Core maintenance principles, such as reliability, reproducibility and quality assurance of the maps for future indication terminology use, are also discussed. The intended audience for this document includes:

a)       Global regulators, pharmaceutical/biopharmaceutical companies, Clinical Research Organizations (CROs) and universities/scientific institutes involved in the development, authorization and marketing of medicinal products

b)       Implementers of IDMP seeking more information about coding of Therapeutic Indications

c)        Healthcare providers

d)       Standards Organizations

e)       Implementers and software vendors developing and implementing terminology map sets

f)         Patients

Previous Editions

Can’t find what you are looking for?

Please contact us at: